کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5537451 | 1402335 | 2016 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Brucella abortus ÎrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
The Brucella abortus general stress response (GSR) system regulates activity of the alternative sigma factor, ÏE1, which controls transcription of approximately 100 genes and is required for persistence in a BALB/c mouse chronic infection model. We evaluated the host response to infection by a B. abortus strain lacking ÏE1 (ÎrpoE1), and identified pathological and immunological features that distinguish ÎrpoE1-infected mice from wild-type (WT), and that correspond with clearance of ÎrpoE1 from the host. ÎrpoE1 infection was indistinguishable from WT in terms of splenic bacterial burden, inflammation and histopathology up to 6 weeks post-infection. However, Brucella-specific serum IgG levels in ÎrpoE1-infected mice were 5 times higher than WT by 4 weeks post-infection, and remained significantly higher throughout the course of a 12-week infection. Total IgG and Brucella-specific IgG levels peaked strongly in ÎrpoE1-infected mice at 6 weeks, which correlated with reduced splenomegaly and bacterial burden relative to WT-infected mice. Given the difference in immune response to infection with wild-type and ÎrpoE1, we tested whether ÎrpoE1 confers protective immunity to wild-type challenge. Mice immunized with ÎrpoE1 completely resisted WT infection and had significantly higher serum titers of Brucella-specific IgG, IgG2a and IFN-γ after WT challenge relative to age-matched naïve mice. We conclude that immunization of BALB/c mice with the B. abortus GSR pathway mutant, ÎrpoE1, elicits an adaptive immune response that confers significant protective immunity against WT infection.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 34, Issue 42, 30 September 2016, Pages 5073-5081
Journal: Vaccine - Volume 34, Issue 42, 30 September 2016, Pages 5073-5081
نویسندگان
Jonathan W. Willett, Julien Herrou, Daniel M. Czyż, Jason X. Cheng, Sean Crosson,